Your browser doesn't support javascript.
loading
Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer.
Vernieri, Claudio; Fucà, Giovanni; Ligorio, Francesca; Huber, Veronica; Vingiani, Andrea; Iannelli, Fabio; Raimondi, Alessandra; Rinchai, Darawan; Frigè, Gianmaria; Belfiore, Antonino; Lalli, Luca; Chiodoni, Claudia; Cancila, Valeria; Zanardi, Federica; Ajazi, Arta; Cortellino, Salvatore; Vallacchi, Viviana; Squarcina, Paola; Cova, Agata; Pesce, Samantha; Frati, Paola; Mall, Raghvendra; Corsetto, Paola Antonia; Rizzo, Angela Maria; Ferraris, Cristina; Folli, Secondo; Garassino, Marina Chiara; Capri, Giuseppe; Bianchi, Giulia; Colombo, Mario Paolo; Minucci, Saverio; Foiani, Marco; Longo, Valter Daniel; Apolone, Giovanni; Torri, Valter; Pruneri, Giancarlo; Bedognetti, Davide; Rivoltini, Licia; de Braud, Filippo.
Affiliation
  • Vernieri C; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. claudio.vernieri@istitutotumori.mi.it claudio.vernieri@ifom.eu licia.rivoltini@istitutotumori.mi.it.
  • Fucà G; IFOM, The FIRC Institute of Molecular Oncology, Milan, Italy.
  • Ligorio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Huber V; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Vingiani A; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Iannelli F; Oncology and Haemato-Oncology Department, University of Milan, Milan, Italy.
  • Raimondi A; Deparment of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Rinchai D; IFOM, The FIRC Institute of Molecular Oncology, Milan, Italy.
  • Frigè G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Belfiore A; Immunology Department, Cancer Program, Sidra Medicine, Doha, Qatar.
  • Lalli L; Department of Experimental Oncology, European Institute of Oncology (IEO), IRCCS, Milan, Italy.
  • Chiodoni C; Deparment of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Cancila V; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Zanardi F; Molecular Immunology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Ajazi A; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy.
  • Cortellino S; IFOM, The FIRC Institute of Molecular Oncology, Milan, Italy.
  • Vallacchi V; IFOM, The FIRC Institute of Molecular Oncology, Milan, Italy.
  • Squarcina P; IFOM, The FIRC Institute of Molecular Oncology, Milan, Italy.
  • Cova A; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Pesce S; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Frati P; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Mall R; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Corsetto PA; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Rizzo AM; Qatar Computing Research Institute, Hamad Bin Khalifa University, Doha, Qatar.
  • Ferraris C; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
  • Folli S; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
  • Garassino MC; Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori. Milan 20133, Italy.
  • Capri G; Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori. Milan 20133, Italy.
  • Bianchi G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Colombo MP; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Minucci S; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Foiani M; Molecular Immunology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Longo VD; Department of Experimental Oncology, European Institute of Oncology (IEO), IRCCS, Milan, Italy.
  • Apolone G; Department of Biosciences, University of Milan, Milan, Italy.
  • Torri V; IFOM, The FIRC Institute of Molecular Oncology, Milan, Italy.
  • Pruneri G; Oncology and Haemato-Oncology Department, University of Milan, Milan, Italy.
  • Bedognetti D; IFOM, The FIRC Institute of Molecular Oncology, Milan, Italy.
  • Rivoltini L; Longevity Institute, School of Gerontology, Department of Biological Sciences, University of Southern California, Los Angeles, California.
  • de Braud F; Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori. Milan, Italy.
Cancer Discov ; 12(1): 90-107, 2022 01.
Article in En | MEDLINE | ID: mdl-34789537
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Colorectal Neoplasms / Fasting / Antineoplastic Agents Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Colorectal Neoplasms / Fasting / Antineoplastic Agents Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Year: 2022 Type: Article